Astria Therapeutics's market cap is currently $433.98M. The company's EPS TTM is $-0.57; its P/E ratio is ―; Astria Therapeutics is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
